» Articles » PMID: 26604130

Bovine Milk-derived Exosomes for Drug Delivery

Overview
Journal Cancer Lett
Specialty Oncology
Date 2015 Nov 26
PMID 26604130
Citations 407
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are biological nanovesicles that are involved in cell-cell communication via the functionally-active cargo (such as miRNA, mRNA, DNA and proteins). Because of their nanosize, exosomes are explored as nanodevices for the development of new therapeutic applications. However, bulk, safe and cost-effective production of exosomes is not available. Here, we show that bovine milk can serve as a scalable source of exosomes that can act as a carrier for chemotherapeutic/chemopreventive agents. Drug-loaded exosomes showed significantly higher efficacy compared to free drug in cell culture studies and against lung tumor xenografts in vivo. Moreover, tumor targeting ligands such as folate increased cancer-cell targeting of the exosomes resulting in enhanced tumor reduction. Milk exosomes exhibited cross-species tolerance with no adverse immune and inflammatory response. Thus, we show the versatility of milk exosomes with respect to the cargo it can carry and ability to achieve tumor targetability. This is the first report to identify a biocompatible and cost-effective means of exosomes to enhance oral bioavailability, improve efficacy and safety of drugs.

Citing Articles

Inhibition of ATP Citrate Lyase by Hydroxycitrate-Loaded Exosomes Suppresses the Survival of Lung Adenocarcinoma Cells.

Phutela K, Ahlawat P, Kaur J, Bal A, Singh N, Singh H Appl Biochem Biotechnol. 2025; .

PMID: 40025393 DOI: 10.1007/s12010-025-05204-5.


Human breast milk-derived exosomes attenuate lipopolysaccharide-induced activation in microglia.

Akinduro O, Kumar S, Chen Y, Thomas B, Hassan Q, Sims B J Neuroinflammation. 2025; 22(1):41.

PMID: 39955566 PMC: 11830176. DOI: 10.1186/s12974-025-03345-2.


GEV Powder: A Modified Product Based on Biovesicles Functioned in Air Pollution PM2.5-Induced Cardiopulmonary Injury.

Zhang X, Ye X, Xie Y, Yang Z, Spanos M, Guo Z Research (Wash D C). 2025; 8:0609.

PMID: 39949511 PMC: 11822167. DOI: 10.34133/research.0609.


Untargeted lipidomics reveals unique lipid signatures of extracellular vesicles from porcine colostrum and milk.

Furioso Ferreira R, Ghaffari M, Ceciliani F, Fontana M, Caruso D, Audano M PLoS One. 2025; 20(2):e0313683.

PMID: 39946395 PMC: 11825007. DOI: 10.1371/journal.pone.0313683.


Unveiling the complex double-edged sword role of exosomes in nasopharyngeal carcinoma.

Huang X, Tang Y PeerJ. 2025; 13():e18783.

PMID: 39822977 PMC: 11737332. DOI: 10.7717/peerj.18783.


References
1.
Tian Y, Li S, Song J, Ji T, Zhu M, Anderson G . A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2013; 35(7):2383-90. DOI: 10.1016/j.biomaterials.2013.11.083. View

2.
Melnik B, John S, Schmitz G . Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy?. J Transl Med. 2014; 12:43. PMC: 3930015. DOI: 10.1186/1479-5876-12-43. View

3.
Yamada T, Inoshima Y, Matsuda T, Ishiguro N . Comparison of methods for isolating exosomes from bovine milk. J Vet Med Sci. 2012; 74(11):1523-5. DOI: 10.1292/jvms.12-0032. View

4.
Lakhal S, Wood M . Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays. 2011; 33(10):737-41. DOI: 10.1002/bies.201100076. View

5.
Batista B, Eng W, Pilobello K, Hendricks-Munoz K, Mahal L . Identification of a conserved glycan signature for microvesicles. J Proteome Res. 2011; 10(10):4624-33. PMC: 3443565. DOI: 10.1021/pr200434y. View